Share Email Print
cover

Proceedings Paper

Study of photodynamic therapy in skin cancers and precancerous lesions
Author(s): Jiabi Wang; Menglin Gao; Shijun Wen; Mianjing Wang
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

Hematoporphyrin photodynamic therapy (HpD-PDT) was used to treat 50 patients (51 lesions) with skin cancers or precancerous lesions. The preliminary results were satisfactory, with 44 cases (45 lesions) obtaining excellent results, 4 cases good, 1 case fair, and 1 case poor. The effective rate was 98%, the significant remission rate 96%, and the complete remission rate 88.2%. Exposure to sunlight should be avoided after HpD injection, since it produces photosensitivity. A follow-up for 1 to 3 years confirmed that HpD-PDT is a good new adjuvant therapy for selected cases. It brings a hopeful future to the treatment of skin cancers.

Paper Details

Date Published: 5 March 1993
PDF: 4 pages
Proc. SPIE 1616, International Conference on Photodynamic Therapy and Laser Medicine, (5 March 1993); doi: 10.1117/12.137009
Show Author Affiliations
Jiabi Wang, Peking Union Medical College Hospital (China)
Menglin Gao, Peking Union Medical College Hospital (China)
Shijun Wen, Peking Union Medical College Hospital (China)
Mianjing Wang, Peking Union Medical College Hospital (China)


Published in SPIE Proceedings Vol. 1616:
International Conference on Photodynamic Therapy and Laser Medicine

© SPIE. Terms of Use
Back to Top